Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy

This publication has 9 references indexed in Scilit:

• Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
  Chest, 2000
• Clinical and dosimetric predictors of radiation-induced esophageal toxicity
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 rtog patients
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
  Journal of Clinical Oncology, 1998
• Tolerance of normal tissue to therapeutic irradiation
  Published by Elsevier ,1991
• A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1990
• Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + xrt) in the treatment of non-small cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 1985